journalsJournal
Journal for ImmunoTherapy of Cancer
aka JITC, J Immunother Cancer
SITC's fully open-access journal: checkpoint-inhibitor and cell-therapy trials, immune-related toxicity management guidelines and immunotherapy biomarkers.
Fully open access, published by BMJ on behalf of the Society for Immunotherapy of Cancer. Publishes phase 1 and 2 immunotherapy trials, SITC clinical practice guidelines on immune-related adverse events and biomarkers, and the SITC annual meeting abstracts. Strong on real-world toxicity and combination strategies.
Publisher
BMJ Group · Society for Immunotherapy of Cancer
Scope
immunotherapy
Website
Access model
open access
Founded
2013
ISSN
2051-1426
Impact factor (2023)
10.3 · Clarivate Journal Citation Reports 2024 (2023 JIF)
Nothing links here yet.